A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sarolaner | CAS 1398609-39-6 - Request Quote

Picture of Sarolaner
SZ CAT No:SZ-S079001
CAS No
1398609-39-6
Mol.F.
C23H18Cl2F4N2O5S
Mol.Wt.
581.4
Inv. Status
In Stock
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Sarolaner is chemically (S)-1-(5'-(5-(3,5-Dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'H-spiro[azetidine-3,1'-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethan-1-one. Sarolaner is supplied with detailed characterization data compliant with regulatory guideline. Sarolaner can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sobrerol.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1398609-39-6

Purchase 1398609-39-6

Order 1398609-39-6

Enquire 1398609-39-6

price of 1398609-39-6

1398609-39-6 Supplier

1398609-39-6 Manufacturer

1398609-39-6 Exporter

buy high quality Sarolaner

Purchase Sarolaner

Sarolaner suppliers

Sarolaner manufacturers

Sarolaner price

Order Sarolaner

Enquire Sarolaner

Sarolaner cost

Sarolaner Supplier

Sarolaner Distributor

Sarolaner for Method Validation

Sobrerol Reference Standard

Sarolaner for ANDA Filing

Sarolaner for Forced Degradation Studies

Sarolaner Identification Standards

Sarolaner for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,